Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Watch Kay Davies explore the latest promising genetic approaches for the diagnosis and treatment of Duchenne Muscular Dystrophy

Davies Group News EDI Events Research

Event video for the Croonian Lecture 2019, delivered by Professor Dame Kay Davies on Wednesday 10 April 2019 at The Royal Society.

Duchenne Muscular Dystrophy therapy is at an exciting stage and Professor Dame Kay Davies was pleased to present the current status of development of these therapies at The Croonian Lecture 2019.

Similar stories

Fellowship to Jose Prius Mengual paves the way to new genetic therapy for epilepsy

Congratulations are in order to Dr Jose Prius Mengual who has been awarded an Emerging Leader Fellowship Award from Epilepsy Research UK and the Nucleic Acid Therapy Accelerator (NATA). With this award, Dr Mengual will develop a new genetic therapy to rebalance protein levels in the neurons affected by epilepsy to prevent seizures.

Fellowship to Hugo Fernandes paves the way to improved treatment options for dementia

Researchers discover why multisensory learning is beneficial for memory

Old and “hangry” monocytes turn from friend to foe under assault

Can humans hibernate?